9- PHARMA MULTI-C...
Follow
Find
32.2K views | +128 today
 
Scooped by Lionel Reichardt / le Pharmageek
onto 9- PHARMA MULTI-CHANNEL MARKETING by PHARMAGEEK
Scoop.it!

P #1: “The Payer” | eyeforpharma

P #1: “The Payer” | eyeforpharma | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Kevin Dolgin's latest article "The Payer" is now online - and it's a real cracker!
more...
No comment yet.
9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK
MULTI CHANNEL MARKETING IN PHARMA / MULTICANAL DANS LA PHARMA
Your new post is loading...
Your new post is loading...
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Marketing
Scoop.it!

Digital Pharma: Can't, won't, don't stop

Digital Pharma: Can't, won't, don't stop | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
As pharma continues to scale the digital curve, James Chases assessment of the landscape paints a familiar picture of progress and encouragement mixed with frustration and pain

Via COUCH.
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Usages professionnels des médias sociaux (blogs, réseaux sociaux...)
Scoop.it!

Priorités des décideurs du digital en 2015 : expérience client, marketing de contenu et mobile - Blog du Modérateur

Priorités des décideurs du digital en 2015 : expérience client, marketing de contenu et mobile - Blog du Modérateur | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

À la fin de chaque année, de nombreux professionnels du web ambitionnent de déterminer les tendances digitales de l'année à venir (NDLR : on peut dire digi


Via Dix-Katre
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Biotech, Pharmas and ideas
Scoop.it!

Johnson & Johnson opening another JLABS accelerator in South San Francisco

Johnson & Johnson opening another JLABS accelerator in South San Francisco | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Life sciences giant Johnson & Johnson Innovation announced the opening of a fourth JLABS accelerator in South San Francisco that will accommodate up to 50 startups that span the healthcare landscape.

Via Herve Ansanay
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Médicaments
Scoop.it!

Médicaments : quand les laboratoires sont rémunérés à la performance

Médicaments : quand les laboratoires sont rémunérés à la performance | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Comment rémunérer l’innovation dans la pharmacie ? A l’instar du Sovaldi, le traitement contre l’hépatite C à plus de 50.000 euros,...

Via Stéphanie Chevrel
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

Quand la #pharma se lance dans un Hackathon-eSanté - l'innovation au service des patients #hcsmeufr #eSanteHack

Quand la #pharma se lance dans un Hackathon-eSanté - l'innovation au service des patients #hcsmeufr #eSanteHack | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Hackathon esanté Novartis, l'innovation au service du patient, venez relever le challenge: www.hackathon-esante.fr
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from industrie pharmaceutique e-sante m-sante
Scoop.it!

Les 10 grandes tendances tech dans l'industrie de la santé

Les 10 grandes tendances tech dans l'industrie de la santé | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
A travers l'exemple de son entreprise, HP, Meg Whitman liste les nouveautés technologiques susceptibles de révolutionner la diffusion, le mode d'administration, le coût et la qualité des services santé dans le monde.

Via Hélène Introvigne
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

PharmagoraPlus 2015 - e-santé et les opportunités pour le pharmaciens d'officine #hcsmeufr

PharmagoraPlus 2015 - e-santé et les opportunités pour le pharmaciens d'officine #hcsmeufr | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
e-santé et les opportunités pour le pharmaciens d'officine
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

DII L’Industrie Pharma à l’ère Digitale - Pourquoi participer ? #hcsmeufr

DII L’Industrie Pharma à l’ère Digitale - Pourquoi participer ? #hcsmeufr | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Conférence Annuelle Digital Pharma 2015. Le 20 mars 2015 à Paris.
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Multichannel Marketing
Scoop.it!

Sanofi joins WHO-backed diabetes mHealth programme

Sanofi joins WHO-backed diabetes mHealth programme | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Becomes
sole pharma partner for Be Healthy, Be Mobile's diabetes arm

Via Stephen Dunn
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Innovation, Big Data, Open Data, Internet of Things, Smart Homes & Cities, 3D printing
Scoop.it!

France : des hackathons pour concevoir des objets connectés | Proxima Mobile : applications et services gratuits sur mobile pour les citoyens

France : des hackathons pour concevoir des objets connectés | Proxima Mobile : applications et services gratuits sur mobile pour les citoyens | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Portail des applications et de services aux citoyens sur téléphone mobile, coordonné par la Délégation aux usages de l'Internet (Ministère de la Recherche / Ministère de l'Industrie) .

Via Celine Sportisse
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Digital Revolution, Digital Health, Internet Psychology, Wellness & IoT
Scoop.it!

80% Of All Online Adults Now Own A Smartphone, Less Than 10% Use Wearables

80% Of All Online Adults Now Own A Smartphone, Less Than 10% Use Wearables | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
If people are looking to Apple and its new smartwatch to kickstart wider consumer interest in wearable computing gadgets, the maker of the iPhone will..

Via Raphaelle LAUBIE
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Social Media and Healthcare
Scoop.it!

FDA Readies Social Media Rules For Big Pharma

FDA Readies Social Media Rules For Big Pharma | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Social media plays an increasingly important role in the marketing and communications plans for pharmaceutical firms.

Trends point to patients and healthcare professionals using social media to research, communicate and influence buying decisions. There are already examples of pharmaceutical firms who are already successfully using social media.

However, many firms have been waiting on the sidelines waiting for guidance from the regulator, the Food and Drug Administration (FDA).

In response to the industry’s request for guidance, the FDA has been busy coming up with some. Over the last 6 months, it has released 3 draft guidance documents for social media.

This is a fast-changing situation with the FDA widely expected to release final guidance on social media very soon.

Acknowledging the keen interest in this area, on July 10th the FDA delivered “The Social Media Draft Guidance Webinar”. The slides for the webinar are available on the FDA’s website.

There are a few recurring points running through all the pieces of FDA guidance, namely:

  • Communications must be balanced, accurate and non-misleading
    • The closer to the creation or adoption of the content, the more likely a firm is responsible for that content.
    • There is no “one-click rule”.  Risk information should be given equal prominence to benefit information, regardless of space constraints.
    • Direct hyperlinks to risk information and/or FDA approved labeling may to be provided from the message, update, ad or tweet as a means to learn more about the product.
  • Organizations must capture and preserve full and proper records
    • Social media communications need to be properly retained, preferably in context, in a format that preserves interactive links
    • Full metadata such as author, date, etc., also needs to be archived

What is clear is that the FDA means business when it comes to the conduct of pharmaceutical firms on social media.  Firms can expect to be held accountable if these standards are not met. Even before the draft guidelines were released, the FDA already demonstrated that it is closely monitoring pharmaceutical firm’s use of social media.  This is illustrated by the warning letters issued to firms it believed had used social media inappropriately, for example:

With the key guidance on the use of social media from the FDA widely expected to be finalized in soon, there is a real likelihood that the FDA will increasingly step up its monitoring program and impose sanctions on non-compliant firms.

However, in response to this recent guidance, we may begin to see more firms explore how they can use social media to build brand awareness, facilitate communities, even drive revenues. These firms need to take thoughtful steps in order to deploy social media compliantly, including, making sure communications are balanced, accurate and non-misleading as well as taking steps to monitor and preserve real-time communications.

Check out these compliant social media guidelines from the FDA:

  1. Responding to Unsolicited Requests for Off-Label Information About Prescription Drugs and Medical Devices (December 2011)
  2. Fulfilling Regulatory Requirements for Postmarking Submissions of Interactive Promotional Media for Prescription Human and Animal Drugs and Biologics (Draft Jan 2014, Final expected July 2014)
  3. FDA Draft Guidance for Industry Internet/Social Media Platforms with Character Space Limitations – Presenting Risk and Benefit Information for Prescription Drugs and Medical Devices (June 2014)
  4. FDA Draft Guidance for Internet/Social Media Platforms: Correcting Independent Third-Party Misinformation About Prescription Drugs and Medical Devices (June 2014)



Via Plus91
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Multichannel Marketing
Scoop.it!

2015 #ePharma Summit highlights, Day Two

2015 #ePharma Summit highlights, Day Two | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Here are some of my personal highlights from day two of the 2015 #ePharma Summit. The ePharma Summit connects pharmaceutical biotech and medical device marketers in bringing together brands, HCPs, and consumers in the era of digital marketing.

Via Stephen Dunn
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from [Pharma & Life sciences: patient-centricity and direct communication to patients - Precision medicine - Patient-focused drug development - Pharma multichannel communication & marketing to healthcare profesionnals] by VAB Traductions
Scoop.it!

4 things you should know about communicating with healthcare professionals

Healthcare professionals are pressed for time now more than ever. Time is filled with entering data into EHR systems and managing an increasing patient load. It can be hard to reach them even at the best of times, but physicians and specialists are undergoing a shift in the way they prefer to communicate. Healthcare organizations looking to connect with these individuals need to keep current marketing trends in mind to achieve success. Our recent HCP Communication Study aimed to uncover the way healthcare professionals prefer to communicate, particularly with the life science industry. Here are the four things you should know:

Via Pharma Guy, VAB Traductions
more...
Pharma Guy's curator insight, March 3, 9:52 AM


Pharma companies could also engage in physician conversations in online HCP communities such as Doximity and Sermo.


What Do Docs Discuss Online?
Will New FDA Guidelines Allow Pharma to Join In?

Pharmaguy interviews Peter Kirk, CEO & Sermo (see Bio), who talks about the nature and value of physician discussions on Sermo and how pharma can engage docs on social media sites and online discussion boards. 

Air Date: Wednesday, 4 March 2015 | 4 PM Eastern

Visit this Pharma Marketing Talk Segment Page and listen live or to the archived audio podcast afterward. 



Rescooped by Lionel Reichardt / le Pharmageek from Pharma Hub
Scoop.it!

Why Partners and Daiichi Sankyo partnered on an AFib remote patient monitoring pilot

The two companies will develop a “mobile wrap-around” for a Daichii Sankyo anticoagulate drug prescribed for atrial fibrillation. Says Kvedar, the intervention will be “cross-therapeutic, but largely will help DSI succeed in the marketplace for their anticoagulate.” Like some of Partners’ other programs, it will involve a wearable monitoring device and an app, through which patients can receive positive feedback from their doctors and from the app itself.


Via Philippe Marchal/Pharma Hub
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

Hackathon e-santé : "le gagnant c'est le patient" #eSanteHack #hcsmeufr

Hackathon e-santé : "le gagnant c'est le patient" #eSanteHack #hcsmeufr | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Hackathon e-santé : "le gagnant c'est le patient" #eSanteHack Un hackathon e santé par Novartis
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from CORPORATE REPUTATION-THE PATIENT PERSPECTIVE
Scoop.it!

142 mental health groups comment on 13 pharma companies


Via PatientView
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma: Trends and Uses Of Mobile Apps and Digital Marketing
Scoop.it!

Exhibit of the Month: Improving Pharmaceutical Innovation

Exhibit of the Month: Improving Pharmaceutical Innovation | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Health Affairs is the leading peer-reviewed journal at the intersection of health, health care, and policy.

Via Richard Meyer, eMedToday
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

e-Santé 2015 : focus sur les dernières tendances dans la Silicon Valley #hcsmeufr

more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Pharma Hub
Scoop.it!

Social Media and Inherent Risks in the Pharmaceutical Industry

Social Media and Inherent Risks in the Pharmaceutical Industry | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
“Pharma is behind on its use of social media, compared to other big companies and especially compared to the rest of the healthcare system”.
Howard J. Luks, Mayo Clinic Center

Via Philippe Marchal/Pharma Hub
more...
No comment yet.
Scooped by Lionel Reichardt / le Pharmageek
Scoop.it!

New Pharma Digital Marketing Benchmarks Show that Online Pharmaceutical Marketing Continues to Drive Brand Awareness, Favorability and Conversions

New Pharma Digital Marketing Benchmarks Show that Online Pharmaceutical Marketing Continues to Drive Brand Awareness, Favorability and Conversions | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
comScore, Inc. (NASDAQ: SCOR), a leader in measuring the digital world, today released results from its eighth annual Online Marketing Effectiveness Benchmarks for the Pharmaceutical Industry, conducted in partnership with marketing innovation consultancy Evolution Road LLC.
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Health, Digital Health, mHealth, Digital Pharma, hcsm latest trends and news (in English)
Scoop.it!

Pharma Marketing Blog: Impact of mHealth on Adherence and Patient Outcomes Needs Improving. How "Open, Crowdsourced" Data from Pharma Can Help

Pharma Marketing Blog: Impact of mHealth on Adherence and Patient Outcomes Needs Improving. How "Open, Crowdsourced" Data from Pharma Can Help | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

Via Celine Sportisse
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from [Pharma & Life sciences: patient-centricity and direct communication to patients - Precision medicine - Patient-focused drug development - Pharma multichannel communication & marketing to healthcare profesionnals] by VAB Traductions
Scoop.it!

Clinical Trials - Pharma in the Twittersphere

Clinical Trials - Pharma in the Twittersphere | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it

"Social media can contribute to nearly every aspect of a clinical trial, from development and recruitment, to sharing important information and findings with patients and researchers. Twitter, in particular, provides the public with a free flow of information and open sharing of ideas, and has been used extensively by patients looking for alternative treatment options. We investigate the unique opportunities provided by Twitter for clinical trials."


Via Plus91, VAB Traductions
more...
No comment yet.
Rescooped by Lionel Reichardt / le Pharmageek from Doctors Hub
Scoop.it!

Poll shows all ages seek digital health tools

Poll shows all ages seek digital health tools | 9- PHARMA MULTI-CHANNEL MARKETING  by PHARMAGEEK | Scoop.it
Millennials and baby boomers have a lot of common a desire for technology that supports health priorities.

Via eMedToday, Philippe Marchal/Pharma Hub
more...
Tanya Kerr's curator insight, February 27, 6:39 PM
Good article that shows the disease or condition is more important motivator. Also that the type of digital media preferred is different per age group.